Pfizer’s Paxlovid Covid-19 drug studied after reports of ‘relapses’
The following is an excerpt from WebMD. U.S. researchers are planning to study how often and why coronavirus levels come back for some Covid-19 patients who take Pfizer’s Paxlovid drug, according to Bloomberg News. “It is a priority,” Clifford Lane, MD, the institute’s deputy director for clinical research, told Bloomberg News, adding that the question is […]
Continue reading Pfizer’s Paxlovid Covid-19 drug studied after reports of ‘relapses’ on sharylattkisson.com.
